ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2008;86:1054-1055. doi:10.1016/j.athoracsur.2007.12.063
© 2008 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pappalardo, F.
Right arrow Articles by Selleng, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pappalardo, F.
Right arrow Articles by Selleng, S.
Related Collections
Right arrow Extracorporeal circulation
Right arrowRelated Article

Correspondence

Postoperative Complications After Cardiac Surgery and HIT: A Word of Caution

Federico Pappalardo, MDa, Andreas Greinacher, MDb, Sixten Selleng, MDb

a Department of Cardiovascular Anesthesia and Intensive Care, San Raffaele Hospital, Via Olgettina 60, Milan, 20132 Italy
b Institut für Immunologie und Transfusionsmedizin, Abteilung Transfusionsmedizin, Ernst-Moritz-Arndt-Universität Greifswald, Sauerbruchstrasse, 17475 Greifswald

(Email: pappalardo.federico@hsr.it; greinach@uni-greifswald.de; sixten.selleng@uni-greifswald.de).

The first 20% of the full text of this article appears below.

To the Editor:

The article by Kerendi and colleagues [1] draws attention to post-cardiac surgery patients who present with thrombocytopenia and who also test positive for anti-Platelet Factor4/heparin antibodies. The authors used a commercially available enzyme-immunoassay (EIA) and found patients testing positive in this assay have an enhanced risk for thromboembolic complications, renal failure, and mortality as compared with antibody negative patients.

However, the study needs some comments, addressing the diagnosis of heparin-induced thrombocytopenia (HIT). . . . [Full Text of this Article]


Related Article

Reply
Faraz Kerendi, Vinod H. Thourani, John D. Puskas, Robert A. Guyton, and Omar M. Lattouf
Ann. Thorac. Surg. 2008 86: 1055. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
F. Kerendi, V. H. Thourani, J. D. Puskas, R. A. Guyton, and O. M. Lattouf
Reply
Ann. Thorac. Surg., September 1, 2008; 86(3): 1055 - 1055.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.